9 Clinical and endocopic improvement following hemopoietic stem cell transplantation in the ASTIC trial
C J Hawkey(NIHR Nottingham Digestive Diseases Biomedical Research Unit), Séverine Vermeire(KU Leuven), Julian Lindsay(Royal North Shore Hospital), Jack Satsangi(Nuffield Orthopaedic Centre), Myriam Labopin(Sorbonne Université), Miquel Rovira, Silvio Danese(IRCCS Ospedale San Raffaele), Matthieu Allez(Inserm), Gerhard Rogler(University Hospital of Zurich), Francesco Onida(Peter MacCallum Cancer Centre), Lauren Clark, A. R. Norman, Sandro Ardizzone(European CanCer Organisation), Simon Travis(University of Oxford), Elizabeth Clark(University of Edinburgh), J.F. Colombel, NH Russell, Dominique Farge(Hôpital Saint-Louis), A Tyndall(University Hospital of Basel), E Ricart
Cited by 11
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease
|Nature Genetics|2017|1.5k
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|996